Resources
122 Results (showing 31 - 40)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 6/3/2022 (updated 3/27/2024)
This session shared recent trend data on opioid and methamphetamine use, overdose rates, and the prevalence of neonatal abstinence syndrome in rural places across the U.S. In addition, data was presented on who is treating opioid use disorder in rural places and on the health workforce providing mental health services for rural patients.
Posted 6/7/2022 (updated 3/27/2024)
We began with a critical examination of the history of family separation in the US to lay the groundwork for a discussion of both provider and patient trust and mistrust. The stigma and discrimination that pregnant, postpartum, and parenting people with substance use disorder was explored. We concluded with concrete suggestions to improve provider wellness, child development, and community cohesion.
Posted 6/7/2022 (updated 3/27/2024)
Cohort-Specific Sessions/Activities and Day 2 Wrap-Up
Posted 5/12/2023 (updated 3/27/2024)
The Policy Center for Maternal Mental Health, in collaboration with the George Washington University, released the first-ever grading of state efforts in addressing maternal mental health. The U.S. received a D, and 42 states received Ds and Fs.
Posted 5/17/2023 (updated 3/27/2024)
Illuminate Colorado, an RCORP Neonatal Abstinence Syndrome (NAS) grantee, and partners presented on their Tough as a Mother campaign. Tough as a Mother is a statewide campaign launched in May 2020 and has been working to decrease the stigma around maternal substance use disorder. The Illuminate Colorado Team provided an overview of their campaign and how others can access the shared resources, followed by time for Q&A.
Posted 6/7/2022 (updated 3/27/2024)
This workshop examined the behavioral health trends of children, youth, and young adults in rural communities and best practices to increase behavioral health treatment outcomes.
Posted 10/17/2023 (updated 3/27/2024)
This webinar will welcome FY23 Neonatal Abstinence Syndrome II recipients to the RCORP program, providing grantees an overview of the RCORP program, an introduction to HRSA’s Office of Federal Assistance Management, and information about the technical assistance and evaluation options for the award.
Posted 5/19/2023 (updated 3/27/2024)
Public Health Institute's (PHI) Cherished Futures for Black Moms and Babies Program is such an important program and example. Racism and toxic stress are root causes for racial disparities in birth outcomes. PHI’s Cherished Futures for Black Moms and Babies is centering the lived experiences of Black women and birthing parents to address this ongoing maternal mortality crisis, bringing together decision-makers from local hospitals, public health departments, health plans and Black women community leaders to identify and put into action systems-change solutions at clinical, institutional and community levels.
Posted 10/23/2023 (updated 3/27/2024)
The Reagan-Udall Foundation partnered with the Food and Drug Administration (FDA) for the "Mitigating Risks from Human Xylazine Exposure" virtual and in-person webinar that occurred early October 2023. This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research that directly supports the mitigation and reduction of risks associated with human exposure to xylazine. The meeting materials, recordings, and slides are now available for viewing.
Posted 5/16/2023 (updated 3/27/2024)
Xylazine, a veterinary tranquilizer not approved for human use, has been increasingly identified in parts of the U.S. illicit drug supply.